Michael Law

Mike

Faculty, Centre for Health Services and Policy Research
Canada Research Chair in Access to Medicines
Professor, UBC School of Population and Public Health

michael.law@ubc.ca
(604) 822-3514


Profile

Dr. Michael Law holds the Canada Research Chair in Access to Medicines, and is a professor in the Centre for Health Services and Policy Research, School of Population and Public Health, at the University of British Columbia.

Michael’s research program focuses on pharmaceutical policy. His work focuses on access to and the use of prescription drugs, including the affordability of prescription drugs, private drug insurance, generic drug pricing, and the impact of pharmacist prescribing. His research program has attracted more than $2.5 million in research funding, including 4 operating grants from CIHR as principal investigator. Currently, his program of research includes studies in several countries, including Canada, Rwanda, Uganda, Namibia, and Colombia.

He has been published in leading medical journals, including BMJ, Archives of Internal Medicine, and CMAJ. This work has been featured in news media such as New Scientist, Forbes, the Globe & Mail, and USA Today. He has also authored commentaries that have appeared in the Toronto Star and Vancouver Sun. His research has had a major impact on generic drug pricing in Canada, leading to policy changes that have saved governments the country more than $100 million every year.

Since his appointment at UBC he has received several notable awards, including a Canada Research Chair (2015), a Distinguished Achievement Award from the UBC Faculty of Medicine (2012), the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the Canadian Institute for Health Services and Policy Research, a Canadian Institutes of Health Research New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.

In 2015, he taught one of UBC’s first edX.org Professional Education courses on Interrupted Time Series Analysis.

Prior to joining UBC, he completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. He has also completed an MSc from the London School of Economics, and worked as a research associate at the University of Auckland, New Zealand.

Education

PhD, Health Policy, Harvard University, 2008
MSc, Health Population and Society, London School of Economics, 2002
BA&Sc, Arts & Sciences Program, McMaster University, 2001

Research Interests

  • Pharmaceutical policy
  • Observational studies
  • Medication adherence and health outcomes
  • Routine data in lower-income countries

Current Projects

  • Cost-related nonadherence to prescription drugs: A multi-method study
  • Impact of physician detailing and sampling for generic atorvastatin

Affiliations and Awards

  • Career Investigator Scholar Award, Michael Smith Foundation for Health Research, 2012-2020
  • New Investigator Award, CIHR, 2010-2015

Current Graduate Students

  • Shania Au, MSc Student, School of Population and Public Health
  • Candice Chiu, MSc Student, School of Population and Public Health
  • Alexandra Lukey, PhD Student, School of Population and Public Health
  • Alison McClean, MSc Student, School of Population and Public Health
  • Richard Musoke, PhD Student, School of Population and Public Health
  • Marie Paul Nisingizwe, PhD Student, School of Population and Public Health
  • Hinda Ruton, PhD Student, School of Population and Public Health
  • Kartik Sharma, MSc Student, School of Population and Public Health
  • Seraphine Zeitouny, PhD Student, School of Population and Public Health

Courses Currently Taught


Recent Publications

Miregwa BN, Holbrook A, Law MR, Lavis JN, Thabane L, Dolovich L, Wilson MG. The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis. CMAJ Open. 2022 Sep 27;10(3):E848-E855. doi: 10.9778/cmajo.20210295. Read more

Hedden L, McCracken RK, Spencer S, Narayan S, Gooderham E, Bach P, Boyd J, Chakanyuka C, Hayashi K, Klimas J, Law M, McGrail K, Nosyk B, Peterson S, Sutherland C, Ti L, Yung S, Cameron F, Fernandez R, Giesler A, Strydom N. Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocol. BMJ Open. 2022 Sep 26;12(9):e067608. doi: 10.1136/bmjopen-2022-067608. Read more

Luz TCB, de Castro AKS, Marques IC, Cota BB, Alves JC, Law MR. Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project. Front Pharmacol. 2022 Sep 2;13:953990. doi: 10.3389/fphar.2022.953990. Read more

McClean AR, Law MR, Harrison M, Bansback N, Gomes T, Tadrous M. Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data. CMAJ. 2022 Apr 19;194(15):E556-E560. doi: 10.1503/cmaj.211478. Read more

McGrail K, Clement F, Law M. The Value of and Need for Health Services and Policy Research that Focuses on Macro System-Level Challenges. Healthc Pap. 2022 Apr;20(3):26-32. doi: 10.12927/hcpap.2022.26846. Read more

Nisingizwe MP, Ndishimye P, Swaibu K, Nshimiyimana L, Karame P, Dushimiyimana V, Musabyimana JP, Musanabaganwa C, Nsanzimana S, Law MR. Effect of unmanned aerial vehicle (drone) delivery on blood product delivery time and wastage in Rwanda: a retrospective, cross-sectional study and time series analysis. Lancet Glob Health. 2022 Apr;10(4):e564-e569. doi: 10.1016/S2214-109X(22)00048-1. Read more

Hofmeister M, Sivakumar A, Clement F, Hayes KN, Law M, Guertin JR, Neville HL, Tadrous M. Trends in Canadian prescription drug purchasing: 2001-2020. J Pharm Policy Pract. 2022 Mar 17;15(1):20. doi: 10.1186/s40545-022-00420-4. Read more

Alves JC, Law MR, Luz TCB. Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project. Value Health Reg Issues. 2022 Mar 17;30:83-90. doi: 10.1016/j.vhri.2022.01.006. Online ahead of print. Read more

Duncan R, Cheng L, Law MR, Shojania K, De Vera MA, Harrison M. The impact of introducing multidisciplinary care assessments on access to rheumatology care in British Columbia: an interrupted time series analysis. BMC Health Serv Res. 2022 Mar 11;22(1):327. doi: 10.1186/s12913-022-07715-x. Read more

Connolly E, Boley EJ, Fejfar DL, Varney PF, Aron MB, Fulcher IR, Lambert W, Ndayizigiye M, Law MR, Mugunga JC, Hedt-Gauthier B; Cross-site COVID-19 Syndromic Surveillance Working Group. Childhood immunization during the COVID-19 pandemic: experiences in Haiti, Lesotho, Liberia and Malawi. Bull World Health Organ. 2022 Feb 1;100(2):115-126C. doi: 10.2471/BLT.21.286774. Epub 2021 Nov 17. Read more

Aranda Z, Binde T, Tashman K, Tadikonda A, Mawindo B, Maweu D, Boley EJ, Mphande I, Dumbuya I, Montaño M, Clisbee M, Mvula MG, Ndayizigiye M, Casella Jean-Baptiste M, Varney PF, Anyango S, Grépin KA, Law MR, Mugunga JC, Hedt-Gauthier B, Fulcher IR; Cross-site COVID-19 Syndromic Surveillance Working Group. Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries. BMJ Glob Health. 2022 Jan;7(1):e007247. doi: 10.1136/bmjgh-2021-007247. Read more

Morrow RL, Mintzes B, Gray G, Law MR, Garrison S, Dormuth CR. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study. Clin Ther. 2021 Dec 23:S0149-2918(21)00493-8. Online ahead of print. Read more

Schummers L, Darling EK, Dunn S, McGrail K, Gayowsky A, Law MR, Laba TL, Kaczorowski J, Norman WV. Abortion Safety and Use with Normally Prescribed Mifepristone in Canada. N Engl J Med. 2021 Dec 8. Online ahead of print. Read more

Zeitouny S, Suda KJ, Mitsantisuk K, Law MR, Tadrous M. Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis. BMJ Glob Health. 2021 Dec;6(12):e006874. Read more

Tadrous M, Shakeri A, Hayes KN, Neville HL, Houlihan J, Clement F, Guertin JR, Law MR, Gomes T. Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023. Canadian Journal of Health Technologies. 2021;1(11). Read more

Older publications